pembrolizumab, bevacizumab & capox for pmmr/mss mcrc in the pochi trial
Published 2 months ago • 173 plays • Length 2:53Download video MP4
Download video MP3
Similar videos
-
1:16
pochi: pembrolizumab, capox and bevacizumab in pmmr/mss colorectal cancer
-
2:38
pembrolizumab combined with xelox and bevacizumab shows higher efficacy than standard therapeuti...
-
2:11
pembrolizumab vs. chemo in first-line mcrc
-
3:01
deeper: m-folfoxiri and cetuximab versus bevacizumab in mcrc
-
2:56
keynote-177: final pfs analysis of pembrolizumab in patients with msi-h/dmmr mcrc
-
4:25
fire-4.5: folfoxiri plus either bevacizumab or cetuximab in mcrc
-
1:05
how will the paradigm trial change the mcrc treatment landscape?
-
0:32
dkn-01 with bevacizumab and chemotherapy in advanced crc
-
1:24
fire-4.5: folfoxiri plus either bevacizumab or cetuximab as 1l treatment of braf v600e-mutant mcrc
-
2:42
paradigm: panitumumab versus bevacizumab in ras-wt mcrc
-
0:56
potential of immunotherapy in mss metastatic colorectal cancer
-
0:11
life of young colon cancer survivor
-
6:56
prior rt may potentially enhance treatment of mss-crc with regorafenib and pembrolizumab
-
4:15
imblaze370 trial in mss mcrc
-
1:35
dr. chu on the role of pembrolizumab in dmmr/msi-h mcrc
-
8:16
beacon crc: first-line bevacizumab in colorectal cancer treatment
-
7:37
debate: msi high colon cancer - upfront chemotherapy
-
2:45
1l folfoxiri plus cetuximab or bevacizumab for ras wild-type mcrc
-
1:13
dr. bekaii-saab on the addition of atezolizumab to capecitabine/bevacizumab in mss mcrc